California’s research sector is facing a new ballot-path fight as Senate Bill 895, known as the California Science and Health Research Bond Act, moves through the state Legislature with a proposal that could ask voters to authorize $23 billion in general obligation bonds for scientific research.
The measure is sponsored by the University of California and authored by state Sen. Scott Wiener. If approved by lawmakers and later voters, it would create a new state entity called the California Foundation for Science and Health Research. That foundation would be tasked with supporting research through grants and loans to universities, research institutes, health care organizations, public agencies, private companies, and other eligible groups.
The proposal arrives as California universities and research institutions continue to monitor shifts in federal science funding. Public legislative records show the bill has advanced through several stages in the Senate, though it has not yet reached voters. The measure would still need to clear the required legislative process before it could appear on a statewide ballot.
What the UC-Backed Bond Would Fund
SB 895 would direct funding toward a wide range of research areas, including biomedical science, behavioral health, climate-related research, agriculture, wildfire resilience, pandemic preparedness, and other scientific fields identified through the proposed foundation.
The bill text says funding decisions would be based on scientific merit, state research priorities, and competitive peer review. The structure is designed to place scientists, public representatives, patient advocates, and other appointed members in a role that would help review and guide funding decisions.
The proposed foundation would be overseen by a governing council. According to the bill text, the council would include members with backgrounds in science, medicine, economics, climate or environmental work, health care, patient advocacy, graduate-level research, and postdoctoral research. The council would have authority to review priorities, approve awards, and oversee program operations.
The legislation also includes public benefit language tied to discoveries that may come from bond-funded research. It states that the foundation should seek to recoup a portion of licensing and royalty revenue from inventions or technologies that result from supported work. The bill also says medicines developed through funded research should be made available to Californians at discounted rates under certain circumstances.
Administrative costs would be limited under the bill. The text places a cap on administrative expenses at no more than 3% of the fund, keeping the primary focus on grants, loans, facilities, research operations, and related scientific work.
Why California’s Research System Is Watching Closely
The University of California system has a large research footprint across medicine, science, technology, agriculture, and public health. Its campuses and medical centers receive support from federal agencies, state programs, nonprofit organizations, industry partners, and other sources.
Public budget analyses have noted that several UC campuses rely heavily on federal research grants, particularly in the health and science fields. UCSF and UC San Diego, for example, have been cited in public reports as campuses with especially large research portfolios connected to federal science agencies.
Supporters of SB 895 have framed the measure as a way to give California a more stable state-level tool for funding scientific work. They have argued that long-running research projects can be difficult to pause or restart when funding changes suddenly. That concern is especially relevant for laboratory work, clinical studies, early-stage medical research, and research tied to large teams or specialized facilities.
The proposal does not replace federal research agencies. Instead, it would create a California-based funding structure that could support selected projects if voters approve the borrowing authority. That distinction is central to the bill’s public positioning: the measure would create a supplemental state funding source, not a substitute for national research programs.
A Large Bond With Oversight Questions Attached
The proposed $23 billion bond would be issued under the state’s general obligation bond process. General obligation bonds are repaid from the state’s general fund, which means the cost would become part of California’s broader long-term debt obligations.
That financial structure may invite close review from lawmakers, fiscal analysts, and voters. Large bond measures often draw questions about repayment timelines, interest costs, oversight, and whether the funded programs should be supported through borrowing rather than annual budget decisions.
SB 895 attempts to address oversight through several provisions. The bill applies public meeting rules to the governing council and peer review panels, though it allows closed sessions for certain matters involving patient information, sensitive medical or scientific research subjects, personnel issues, and other protected material.
The bill also requires competitive review for research awards. That process may help separate eligible scientific projects from weaker applications, though final implementation would depend on how the foundation is staffed, how priorities are written, and how the council manages grant and loan decisions.
The public benefit provisions may also receive attention. The bill’s language around licensing fees, royalty revenue, discounted medicines, and possible public production through CalRx suggests that lawmakers are trying to connect research funding to broader public access. Those provisions may become part of the debate if the measure moves closer to the ballot.
The Ballot Path Could Turn Science Funding Into a Statewide Issue
SB 895 has not become a ballot measure yet. It remains a legislative proposal and would need to clear the state process before voters could consider it. Public tracking records show it has continued moving through the Senate, but final placement on the ballot depends on additional approvals.
If the measure reaches voters, California would see a statewide debate over whether science and health research should receive a dedicated bond-backed funding stream. The campaign could draw attention from universities, medical centers, patient groups, labor organizations, taxpayer advocates, public health leaders, and scientific institutions.
The timing adds weight to the issue. Research organizations across the country have been reviewing federal funding changes, grant delays, legal disputes, and agency-level uncertainty. California’s proposal would give the state a direct role in supporting selected research priorities, while also asking voters to accept a sizable borrowing plan.
For UC and other supporters, the bill offers a path to maintain research capacity, support facilities, and keep scientific work moving during a period of funding uncertainty. For skeptics, the key questions may center on debt, accountability, and whether voters should authorize such a large bond for a research program managed through a newly created foundation.
